Home/Filings/4/0001387131-21-002886
4//SEC Filing

MORRIS JESSICA EDGAR 4

Accession 0001387131-21-002886

CIK 0001430306other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 5:49 PM ET

Size

7.8 KB

Accession

0001387131-21-002886

Insider Transaction Report

Form 4
Period: 2021-02-23
MORRIS JESSICA EDGAR
Chief Operating Officer
Transactions
  • Award

    Stock Option

    2021-02-23+540,000540,000 total
    Exercise: $1.22From: 2022-02-23Exp: 2031-02-23Common Stock (540,000 underlying)
  • Award

    Stock Option

    2021-02-23+540,000540,000 total
    Exercise: $1.53From: 2022-02-23Exp: 2031-02-23Common Stock (540,000 underlying)
Footnotes (2)
  • [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
  • [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1
  • filerCIK 0001656531

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:49 PM ET
Size
7.8 KB